technetium tc 99m sestamibi has been researched along with prednisone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertocchi, C; Comotti, B; D'Adda, F; Medolago, G; Motta, T; Orlandi, C; Pitì, A; Rottoli, MR; Tespili, M; Virotta, G | 1 |
Barbieri, A; Leite, WA; Oliveira Filho, JA; Sato, EI; Sella, EM | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and prednisone
Article | Year |
---|---|
Abnormal uptake of technetium-99m hexakis-2-methoxyisobutylisonitrile in a primary cardiac lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Organotechnetium Compounds; Prednisone; Radionuclide Imaging; Remission Induction; Technetium Tc 99m Sestamibi; Vincristine | 1992 |
Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Chi-Square Distribution; Cholesterol, HDL; Coronary Disease; Diabetes Complications; Dipyridamole; Female; Fingers; Heart; Humans; Logistic Models; Lupus Erythematosus, Systemic; Middle Aged; Perfusion; Prednisone; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasculitis; Vasodilator Agents | 2003 |